Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Long non-coding and coding RNAs characterization in Peripheral Blood Mononuclear Cells and Spinal Cord from Amyotrophic Lateral Sclerosis patients.

Gagliardi S, Zucca S, Pandini C, Diamanti L, Bordoni M, Sproviero D, Arigoni M, Olivero M, Pansarasa O, Ceroni M, Calogero R, Cereda C.

Sci Rep. 2018 Feb 5;8(1):2378. doi: 10.1038/s41598-018-20679-5.

2.

Medium-term follow-up of 149 mobile-bearing total knee arthroplasties and evaluation of prognostic factors influencing outcomes.

Rosso F, Cottino U, Olivero M, Bonasia DE, Bruzzone M, Rossi R.

J Orthop Surg (Hong Kong). 2018 Jan-Apr;26(1):2309499017754092. doi: 10.1177/2309499017754092.

3.

Heat-shock protein 27 (HSP27, HSPB1) is synthetic lethal to cells with oncogenic activation of MET, EGFR and BRAF.

Konda JD, Olivero M, Musiani D, Lamba S, Di Renzo MF.

Mol Oncol. 2017 Jun;11(6):599-611. doi: 10.1002/1878-0261.12042. Epub 2017 May 8.

4.

[Italian validation of the Chemotherapy Induced Taste Alteration Scale].

Campagna S, Gonella S, Stuardi M, Sperlinga R, Cerponi M, Olivero M, Giuliano PL, Marchese R, Carnovali E, Pedersini R, Berchialla P, Dimonte V.

Assist Inferm Ric. 2016 Jan-Mar;35(1):22-8. doi: 10.1702/2228.24016. Italian.

PMID:
27183423
5.

Multipath interference characterization of bend-insensitive optical fibers and short jumpers.

Olivero M, Greborio L, Orta R, Pellegrino P, Perrone G, Regio P.

Appl Opt. 2016 Apr 10;55(11):2998-3005. doi: 10.1364/AO.55.002998.

PMID:
27139866
6.

A Website Intervention to Increase Knowledge About Living Kidney Donation and Transplantation Among Hispanic/Latino Dialysis Patients.

Gordon EJ, Feinglass J, Carney P, Vera K, Olivero M, Black A, O'Connor KG, Baumgart JM, Caicedo JC.

Prog Transplant. 2016 Mar;26(1):82-91. doi: 10.1177/1526924816632124.

PMID:
27136254
7.

The integrin-linked kinase-associated phosphatase (ILKAP) is a regulatory hub of ovarian cancer cell susceptibility to platinum drugs.

Lorenzato A, Torchiaro E, Olivero M, Di Renzo MF.

Eur J Cancer. 2016 Jun;60:59-68. doi: 10.1016/j.ejca.2016.02.022. Epub 2016 Apr 13.

PMID:
27065457
8.

Xenopatients show the need for precision medicine approach to chemotherapy in ovarian cancer.

Erriquez J, Olivero M, Mittica G, Scalzo MS, Vaira M, De Simone M, Ponzone R, Katsaros D, Aglietta M, Calogero R, Di Renzo MF, Valabrega G.

Oncotarget. 2016 May 3;7(18):26181-91. doi: 10.18632/oncotarget.8325.

9.

Peritoneal and hematogenous metastases of ovarian cancer cells are both controlled by the p90RSK through a self-reinforcing cell autonomous mechanism.

Torchiaro E, Lorenzato A, Olivero M, Valdembri D, Gagliardi PA, Gai M, Erriquez J, Serini G, Di Renzo MF.

Oncotarget. 2016 Jan 5;7(1):712-28. doi: 10.18632/oncotarget.6412.

10.

A Culturally Targeted Website for Hispanics/Latinos About Living Kidney Donation and Transplantation: A Randomized Controlled Trial of Increased Knowledge.

Gordon EJ, Feinglass J, Carney P, Vera K, Olivero M, Black A, OʼConnor K, MacLean J, Nichols S, Sageshima J, Preczewski L, Caicedo JC.

Transplantation. 2016 May;100(5):1149-60. doi: 10.1097/TP.0000000000000932.

PMID:
26444846
11.

TOP2A gene copy gain predicts response of epithelial ovarian cancers to pegylated liposomal doxorubicin: TOP2A as marker of response to PLD in ovarian cancer.

Erriquez J, Becco P, Olivero M, Ponzone R, Maggiorotto F, Ferrero A, Scalzo MS, Canuto EM, Sapino A, Verdun di Cantogno L, Bruna P, Aglietta M, Di Renzo MF, Valabrega G.

Gynecol Oncol. 2015 Sep;138(3):627-33. doi: 10.1016/j.ygyno.2015.06.025. Epub 2015 Jun 20.

PMID:
26100858
12.

An interactive, bilingual, culturally targeted website about living kidney donation and transplantation for hispanics: development and formative evaluation.

Gordon EJ, Feinglass J, Carney P, Ramirez D, Olivero M, O'Connor K, MacLean J, Brucker J, Caicedo JC.

JMIR Res Protoc. 2015 Apr 20;4(2):e42. doi: 10.2196/resprot.3838.

13.

The stress phenotype makes cancer cells addicted to CDT2, a substrate receptor of the CRL4 ubiquitin ligase.

Olivero M, Dettori D, Arena S, Zecchin D, Lantelme E, Di Renzo MF.

Oncotarget. 2014 Aug 15;5(15):5992-6002.

14.

PIM2 kinase is induced by cisplatin in ovarian cancer cells and limits drug efficacy.

Musiani D, Hammond DE, Cirillo L, Erriquez J, Olivero M, Clague MJ, Di Renzo MF.

J Proteome Res. 2014 Nov 7;13(11):4970-82. doi: 10.1021/pr500651n. Epub 2014 Aug 15.

15.

Hispanic/Latino concerns about living kidney donation: a focus group study.

Gordon EJ, Mullee JO, Ramirez DI, MacLean J, Olivero M, Feinglass J, Carney P, O'Connor K, Caicedo JC.

Prog Transplant. 2014 Jun;24(2):152-62. doi: 10.7182/pit2014946.

PMID:
24919732
16.

Heat-shock protein 27 (HSP27, HSPB1) is up-regulated by MET kinase inhibitors and confers resistance to MET-targeted therapy.

Musiani D, Konda JD, Pavan S, Torchiaro E, Sassi F, Noghero A, Erriquez J, Perera T, Olivero M, Di Renzo MF.

FASEB J. 2014 Sep;28(9):4055-67. doi: 10.1096/fj.13-247924. Epub 2014 Jun 5.

17.

HSP27 is required for invasion and metastasis triggered by hepatocyte growth factor.

Pavan S, Musiani D, Torchiaro E, Migliardi G, Gai M, Di Cunto F, Erriquez J, Olivero M, Di Renzo MF.

Int J Cancer. 2014 Mar 15;134(6):1289-99. doi: 10.1002/ijc.28464. Epub 2013 Sep 18.

18.

AKT activation drives the nuclear localization of CSE1L and a pro-oncogenic transcriptional activation in ovarian cancer cells.

Lorenzato A, Biolatti M, Delogu G, Capobianco G, Farace C, Dessole S, Cossu A, Tanda F, Madeddu R, Olivero M, Di Renzo MF.

Exp Cell Res. 2013 Oct 15;319(17):2627-36. doi: 10.1016/j.yexcr.2013.07.030. Epub 2013 Aug 13.

PMID:
23948303
19.

Photonic bandgap confinement in an all-solid tellurite-glass photonic crystal fiber.

Lousteau J, Scarpignato G, Athanasiou GS, Mura E, Boetti N, Olivero M, Benson T, Sewell P, Abrate S, Milanese D.

Opt Lett. 2012 Dec 1;37(23):4922-4. doi: 10.1364/OL.37.004922.

PMID:
23202091
20.

IRF-1 expression is induced by cisplatin in ovarian cancer cells and limits drug effectiveness.

Pavan S, Olivero M, Corà D, Di Renzo MF.

Eur J Cancer. 2013 Mar;49(4):964-73. doi: 10.1016/j.ejca.2012.09.024. Epub 2012 Oct 15.

PMID:
23079474
21.

Analysis of Faraday effect in multimode tellurite glass optical fiber for magneto-optical sensing and monitoring applications.

Shiyu Y, Lousteau J, Olivero M, Merlo M, Boetti N, Abrate S, Chen Q, Chen Q, Milanese D.

Appl Opt. 2012 Jul 1;51(19):4542-6. doi: 10.1364/AO.51.004542.

PMID:
22772128
22.

Cells lacking the fumarase tumor suppressor are protected from apoptosis through a hypoxia-inducible factor-independent, AMPK-dependent mechanism.

Bardella C, Olivero M, Lorenzato A, Geuna M, Adam J, O'Flaherty L, Rustin P, Tomlinson I, Pollard PJ, Di Renzo MF.

Mol Cell Biol. 2012 Aug;32(15):3081-94. doi: 10.1128/MCB.06160-11. Epub 2012 May 29.

23.

The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C.

Lorenzato A, Martino C, Dani N, Oligschläger Y, Ferrero AM, Biglia N, Calogero R, Olivero M, Di Renzo MF.

FASEB J. 2012 Jun;26(6):2446-56. doi: 10.1096/fj.11-195982. Epub 2012 Mar 2.

PMID:
22389439
24.

The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors.

Dani N, Olivero M, Mareschi K, van Duist MM, Miretti S, Cuvertino S, Patané S, Calogero R, Ferracini R, Scotlandi K, Fagioli F, Di Renzo MF.

J Bone Miner Res. 2012 Jun;27(6):1322-34. doi: 10.1002/jbmr.1578.

25.

Fumarase tumor suppressor gene and MET oncogene cooperate in upholding transformation and tumorigenesis.

Costa B, Dettori D, Lorenzato A, Bardella C, Coltella N, Martino C, Cammarata C, Carmeliet P, Olivero M, Di Renzo MF.

FASEB J. 2010 Aug;24(8):2680-8. doi: 10.1096/fj.09-146928. Epub 2010 Mar 30.

PMID:
20354140
26.

met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma.

De Maria R, Miretti S, Iussich S, Olivero M, Morello E, Bertotti A, Christensen JG, Biolatti B, Levine RA, Buracco P, Di Renzo MF.

J Pathol. 2009 Jul;218(3):399-408. doi: 10.1002/path.2549.

27.

17beta-oestradiol-induced gene expression in cattle prostate: biomarkers to detect illegal use of growth promoters.

De Maria R, Divari S, Goria M, Bollo E, Cannizzo FT, Olivero M, Barbarino G, Biolatti B.

Vet Rec. 2009 Apr 11;164(15):459-64.

28.

Low-cost fiber Bragg grating vibroacoustic sensor for voice and heartbeat detection.

Tosi D, Olivero M, Perrone G.

Appl Opt. 2008 Oct 1;47(28):5123-9.

PMID:
18830301
29.

Early diagnosis of multiple primary amelanotic/hypomelanotic melanoma using dermoscopy.

Zell D, Kim N, Olivero M, Elgart G, Rabinovitz H.

Dermatol Surg. 2008 Sep;34(9):1254-7. doi: 10.1111/j.1524-4725.2008.34270.x. Epub 2008 Jun 28. No abstract available.

PMID:
18554289
30.

A mouse model of pulmonary metastasis from spontaneous osteosarcoma monitored in vivo by Luciferase imaging.

Miretti S, Roato I, Taulli R, Ponzetto C, Cilli M, Olivero M, Di Renzo MF, Godio L, Albini A, Buracco P, Ferracini R.

PLoS One. 2008 Mar 19;3(3):e1828. doi: 10.1371/journal.pone.0001828.

31.

A cancer-predisposing "hot spot" mutation of the fumarase gene creates a dominant negative protein.

Lorenzato A, Olivero M, Perro M, Brière JJ, Rustin P, Di Renzo MF.

Int J Cancer. 2008 Feb 15;122(4):947-51.

32.

Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling.

Cantiani L, Manara MC, Zucchini C, De Sanctis P, Zuntini M, Valvassori L, Serra M, Olivero M, Di Renzo MF, Colombo MP, Picci P, Scotlandi K.

Cancer Res. 2007 Aug 15;67(16):7675-85.

33.

The therapeutic potential of hepatocyte growth factor to sensitize ovarian cancer cells to cisplatin and paclitaxel in vivo.

Bardella C, Dettori D, Olivero M, Coltella N, Mazzone M, Di Renzo MF.

Clin Cancer Res. 2007 Apr 1;13(7):2191-8.

34.

Genes regulated by hepatocyte growth factor as targets to sensitize ovarian cancer cells to cisplatin.

Olivero M, Ruggiero T, Saviozzi S, Rasola A, Coltella N, Crispi S, Di Cunto F, Calogero R, Di Renzo MF.

Mol Cancer Ther. 2006 May;5(5):1126-35.

35.

MET overexpression turns human primary osteoblasts into osteosarcomas.

Patanè S, Avnet S, Coltella N, Costa B, Sponza S, Olivero M, Vigna E, Naldini L, Baldini N, Ferracini R, Corso S, Giordano S, Comoglio PM, Di Renzo MF.

Cancer Res. 2006 May 1;66(9):4750-7.

36.

UV-written Integrated Optical 1xN Splitters.

Olivero M, Svalgaard M.

Opt Express. 2006 Jan 9;14(1):162-70.

PMID:
19503327
37.

Direct UV-written broadband directional planar waveguide couplers.

Olivero M, Svalgaard M.

Opt Express. 2005 Oct 17;13(21):8390-9.

PMID:
19498869
38.

Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer.

De Maria R, Olivero M, Iussich S, Nakaichi M, Murata T, Biolatti B, Di Renzo MF.

Cancer Res. 2005 Feb 1;65(3):907-12.

39.

Truncated RON tyrosine kinase drives tumor cell progression and abrogates cell-cell adhesion through E-cadherin transcriptional repression.

Bardella C, Costa B, Maggiora P, Patane' S, Olivero M, Ranzani GN, De Bortoli M, Comoglio PM, Di Renzo MF.

Cancer Res. 2004 Aug 1;64(15):5154-61.

40.

Deletion in a (T)8 microsatellite abrogates expression regulation by 3'-UTR.

Ruggiero T, Olivero M, Follenzi A, Naldini L, Calogero R, Di Renzo MF.

Nucleic Acids Res. 2003 Nov 15;31(22):6561-9.

41.
42.

Molecular analysis of the GNAS1 gene for the correct diagnosis of Albright hereditary osteodystrophy and pseudohypoparathyroidism.

De Sanctis L, Romagnolo D, Olivero M, Buzi F, Maghnie M, Scirè G, Crino A, Baroncelli GI, Salerno M, Di Maio S, Cappa M, Grosso S, Rigon F, Lala R, De Sanctis C, Dianzani I.

Pediatr Res. 2003 May;53(5):749-55. Epub 2003 Mar 5.

PMID:
12621129
43.

Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion.

Lorenzato A, Olivero M, Patanè S, Rosso E, Oliaro A, Comoglio PM, Di Renzo MF.

Cancer Res. 2002 Dec 1;62(23):7025-30.

44.

Expression of Hepatocyte Growth Factor (HGF) and its Receptor (MET) in Medullary Carcinoma of the Thyroid.

Papotti M, Olivero M, Volante M, Negro F, Prat M, Comoglio PM, DiRenzo MF.

Endocr Pathol. 2000 Spring;11(1):19-30.

PMID:
12114654
45.

MET receptor is overexpressed but not mutated in oral squamous cell carcinomas.

Morello S, Olivero M, Aimetti M, Bernardi M, Berrone S, Di Renzo MF, Giordano S.

J Cell Physiol. 2001 Dec;189(3):285-90.

PMID:
11748586
46.

The expression of Met/hepatocyte growth factor receptor gene in giant cell tumors of bone and other benign musculoskeletal tumors.

Ferracini R, Scotlandi K, Cagliero E, Acquarone F, Olivero M, Wunder J, Baldini N.

J Cell Physiol. 2000 Aug;184(2):191-6.

PMID:
10867643
47.

Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases.

Cortesina G, Martone T, Galeazzi E, Olivero M, De Stefani A, Bussi M, Valente G, Comoglio PM, Di Renzo MF.

Int J Cancer. 2000 May 20;89(3):286-92.

48.

Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas.

Di Renzo MF, Olivero M, Martone T, Maffe A, Maggiora P, Stefani AD, Valente G, Giordano S, Cortesina G, Comoglio PM.

Oncogene. 2000 Mar 16;19(12):1547-55.

49.

Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family.

Olivero M, Valente G, Bardelli A, Longati P, Ferrero N, Cracco C, Terrone C, Rocca-Rossetti S, Comoglio PM, Di Renzo MF.

Int J Cancer. 1999 Aug 27;82(5):640-3.

50.

Control of invasive growth by the HGF receptor family.

Maggiora P, Gambarotta G, Olivero M, Giordano S, Di Renzo MF, Comoglio PM.

J Cell Physiol. 1997 Nov;173(2):183-6. Review. No abstract available.

PMID:
9365519

Supplemental Content

Loading ...
Support Center